HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
HIGH THROUGHPUT PROTEIN-PROTEIN INTERACTION INTERROGATION IN CANCER
批准号:
8561414
负责人:
HAIAN FU
金额:
$82.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-17 至 2017-04-30
关键词:
Atlas of Cancer Mortality in the United StatesBindingBioinformaticsBiological AssayBiological ModelsBiologyCandidate Disease GeneCatalogingCatalogsCellsChemicalsClinical DataCollaborationsCritical PathwaysDataData AnalysesData SetDatabasesDetectionDevelopmentDimensionsElementsFoundationsFutureGenesGenomicsGlioblastomaGoalsIn VitroInformaticsLeadMalignant NeoplasmsMalignant neoplasm of ovaryMapsMediatingMethodsMiningModelingMolecularMolecular TargetNeoplasm MetastasisNetwork-basedOncogene ProteinsOncogenicOutputPathway interactionsPhosphotransferasesPilot ProjectsProcessProtein-Protein Interaction MapProteinsResearchRoleScienceScreening procedureSignal TransductionTechnologyTestingThe Cancer Genome AtlasTherapeuticTherapeutic InterventionTranslationsTumor Suppressor ProteinsValidationassay developmentbasecancer genomecancer genomicscancer typedata integrationdata miningdata sharingdrug discoveryexperiencefunctional genomicshigh throughput screeninghigh throughput technologyinnovationmembernovelnovel strategiesnovel therapeuticsprogramsprotein protein interactionreceptorresearch studysmall molecule librariessoftware systemstherapeutic developmenttherapeutic targettooltumortumor initiationtumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Emory Molecular Interaction Center for Functional Genomics (MicFG), with its expertise in
high throughput technologies for the study of protein-protein interactions (PPI) , productive track
record of innovative HTS assay development for chemical lead discovery, and proven cancer
genomics mining, database, and data integration capabilities, seeks to become a node in the
NCI Cancer Target Discovery and Development (CTDD) Network. Genomic alterations in
various tumor types, as revealed by cancer genomics initiatives such as The Cancer Genome
Atlas (TCGA), often lead to re-wired protein-protein interaction networks, which in turn drive
tumor initiation and progression. Thus, identifying prominent PPI nodes and networks among
oncoproteins and tumor suppressors as enriched by various genomics datasets and the
validation of their critical roles in tumorigenesis and progression are expected to reveal an
entirely new class of PPI-based cancer targets for therapeutic development. To achieve this
goal, we propose to utilize our established high throughput PPI technologies to interrogate
cancer genomics information through a team science approach (i) to rapidly establish oncogenic
PPI networks of selected cancer types based on TCGA and other genomic datasets, (ii) to
validate functional roles of key PPI nodes or hubs in tumorigenesis and progression, (iii) to
develop HTS assays for critical tumor-associated PPIs to enrich the therapeutic target pipeline
of the NCI and the drug discovery field, and (iv) to leverage our informatics capability for
genomics data mining for prioritized PPI mapping, functional PPI validation, and trans-network
data sharing and collaboration. We aim to bridge the gap between vast genomic datasets and
therapeutic discovery by establishing and interrogating the cancer PPI target space. With our
PPI expertise and state-of-the-art high throughput technologies, which is highly adaptable to a
variety of outputs, we intend to function as an active, synergistic member in collaborative trans-
Network projects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core 1: Administration
-
批准号:10411669
-
项目类别:
-
资助金额:$16.68万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
-
批准号:10411665
-
项目类别:
-
资助金额:$222.93万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Deciphering LKB1-associated immunotherapy resistance in lung adenocarcinoma (LUAD)
-
批准号:10631134
-
项目类别:
-
资助金额:$216.48万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
-
批准号:10631142
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Project 2: Reversing STING-mediated immunosuppression in LKB1-mutant lung adenocarcinoma
-
批准号:10411667
-
项目类别:
-
资助金额:$39.49万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Core 1: Administration
-
批准号:10631158
-
项目类别:
-
资助金额:$15.94万
-
财政年份:2022
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10685410
-
项目类别:
-
资助金额:$183.99万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10210194
-
项目类别:
-
资助金额:$182.51万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10685427
-
项目类别:
-
资助金额:$7.68万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10210204
-
项目类别:
-
资助金额:$8.98万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:10459437
-
项目类别:
-
资助金额:$183.99万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Emory University Lung Cancer SPORE
-
批准号:9975749
-
项目类别:
-
资助金额:$186.51万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Developmental Research Program
-
批准号:10459443
-
项目类别:
-
资助金额:$9.7万
-
财政年份:2019
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:10210364
-
项目类别:
-
资助金额:$93.24万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:9752497
-
项目类别:
-
资助金额:$90.5万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
-
批准号:9363451
-
项目类别:
-
资助金额:$79.13万
-
财政年份:2017
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8660662
-
项目类别:
-
资助金额:$83.43万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8470586
-
项目类别:
-
资助金额:$80.85万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
High Throughput Protein-Protein Interaction Interrogation in Cancer
-
批准号:8323746
-
项目类别:
-
资助金额:$82.6万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
DISCOVERY AND DEVELOPMENTAL THERAPEUTICS PROGRAM
-
批准号:8512132
-
项目类别:
-
资助金额:$2.42万
-
财政年份:2012
-
负责人:HAIAN FU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: